Bright Minds Biosciences (TSE:DRUG)
CNQX:DRUG

Bright Minds Biosciences (DRUG) Technical Analysis

7 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Bright Minds Biosciences is a Sell.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 1.42, while Bright Minds Biosciences’s (DRUG) share price is C$1.45, making it a Buy.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 1.46, while Bright Minds Biosciences’s (DRUG) share price is C$1.45, making it a Sell.

Bright Minds Biosciences (DRUG) Pivot Points

Jul 27, 2024, 08:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.38
1.42
1.43
1.47
1.48
1.52
1.53
Fibonacci
1.42
1.44
1.45
1.47
1.49
1.50
1.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Jul 27, 2024, 08:50 PM
Period
Simple
Exponential
MA5
1.44Buy
1.44Buy
MA10
1.44Buy
1.43Buy
MA20
1.41Buy
1.42Buy
MA50
1.46Sell
1.46Sell
MA100
1.55Sell
1.62Sell
MA200
1.86Sell
1.95Sell
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 1.43, while Bright Minds Biosciences’s (DRUG) share price is C$1.45, making it a Buy.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 1.62, while Bright Minds Biosciences’s (DRUG) share price is C$1.45, making it a Sell.
Bright Minds Biosciences’s (DRUG) stock price is C$1.45 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 1.46, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is C$1.45 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 1.55, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is C$1.45 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 1.86, creating a Sell signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Jul 27, 2024, 08:50 PM
Name
Value
Implied Action
RSI (14)
57.43
Neutral
STOCH (9,6)
50.14
Neutral
STOCHRSI (14)
61.54
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
23.91
Neutral
Williams %R
-38.46
Buy
CCI (14)
110.89
Sell
ATR (14)
0.03
-
Ultimate Oscillator
20.41
Sell
ROC
5.07
Buy
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 57.43, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 23.91, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is 110.89, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is 5.07, creating a Buy signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Hold.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 57.43, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is <0.01, which suggests DRUG is a Sell.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 1.44, which suggests DRUG is a Buy.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 1.41, which suggests DRUG is a Buy.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 1.46, which suggests DRUG is a Sell.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 1.86, which suggests DRUG is a Sell.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -38.46, which suggests DRUG is a Buy.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is 110.89, which suggests DRUG is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis